References
- Asimakopoulos FA, Green AR. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 1996;95:219.
- Macdonald D, Sheerin SM, Cross NC, et al. An atypical myeloproliferative disorder with t(8;13) (p11;q12): A third case. Br J Haematol 1994;86:879–880.
- Invernizzi R, Benatti C, Grino M, et al. A further case of myeloproliferative syndrome with reciprocal translocation (8;13) (p11;q12). Haematologica 2004;89(2) :239–241.
- Reiter A, Sohal J, Kulkarni S, et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 1998; 92(5):1735–1742.
- Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/ lymphoma syndrome. Nat Genet 1998;18:84–87.
- Leslie J, Barker T, Glancy M, et al. t(8;13)(p11;q12) translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Br J Haematol 1994;86: 876–878.
- Reiter A, Sohal J, Kulkarni S, et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 199892:1735-1742.
- Salles MT, Neyra O, Taja L, et al. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma. Cancer Genet Cytogenet 1992;59:80–83.
- Rooney DE, Czepulkowski BH, editors. Human cytogenetics: A practical approach. Oxford: IRL Press; 1989. p 135–158.
- Virchis A, Koh M, Rankin P, et al. Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. Br J Haematol January 2004;124 (1): 26–32.
- Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992;16: 236–245.
- Macdonald D, Aguiar RCT, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review. Leukemia 1995;9: 1628-1630.
- Fagan K, Hyde S, Harrison P. Translocation (8;13) and T-cell lymphoma. Cancer Genet Cytogenet 1993;65: 71–73.
- Inborn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyper-plasia/malignancy associated with t(8;13)(p11;q11): Descrip-tion of a distinctive clinicopathologic entity. Blood 1995;85: 1881-1887.
- Huret JL, Leroux D, Bernheim A. t(8;13)(p12;q12). Atlas Genet Cytogenet Oncol Haematol March 1998;.
- Pébusque MJ, Cross NCP. t(8;13)(p12;q12). Atlas Genet Cytogenet Oncol Haematol December 2000.
- Suzan F, Guasch G, Tere C, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol 2003;121:312–314.
- Ollendorff V, Guasch G, Isnardon D, et al. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder associated t(8;13) translocation. J Biol Chem 1999; 274:26922–26930.
- Kulkarni S, Reiter A, Smedley D, et al. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome. Genomics 1999;55:118–121.
- Popovici C, Adelaide J, Endorff V, et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloprolifera-tive disorder with t(8;13)(p12;q12). Proc Natl Acad Sci USA 1998;95: 5712–5717.
- Chen J, DeAngelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growthfactor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101(40):14479–14484.